Plain-English translation of NCT07025785 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing whether a simple blood test can detect tiny amounts of cancer cells remaining after breast cancer surgery. Researchers will collect a small tissue sample from your surgery and blood samples every three months to look for circulating tumor DNA—genetic material from cancer cells that may be floating in your bloodstream. The goal is to help doctors figure out which patients might benefit from stronger treatments to prevent the cancer from coming back.
Some patients with early-stage breast cancer that has spread to nearby lymph nodes are at higher risk of the cancer returning, but doctors don't always know which patients need more aggressive treatment. This study hopes to use blood tests to identify these higher-risk patients earlier, so they can receive additional therapy while the cancer may still be curable.
You likely qualify if…
You likely don't qualify if…
You will have a small tissue sample collected from your surgery (or it may already be available from your medical records). Then, every three months, you will have a blood draw to test for cancer DNA. Researchers will track your health and any treatments you receive over time, then analyze whether the blood test results matched what actually happened with your cancer. Your doctor will not see these blood test results during the study—the analysis will happen after the fact to see how well the test works.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States